Addex Therapeutics logo

Addex Therapeutics

Allosteric modulators for Human Health

19 employees · est. 2002 · Plan-les-ouates, Switzerland

VS
Bionomics Ltd logo

Bionomics Ltd

Developing novel drug candidates to transform the lives of patients with anxiety and stressor-related CNS disorders

30 employees · est. 1999 · Australia

Bionomics Ltd is the older company (2002 vs 1999).

Side-by-Side Comparison

Addex Therapeutics Bionomics Ltd
Founded
2002 1999 older
Headquarters
Plan-les-ouates, Switzerland Australia
Employees
19 30
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care
Funding Stage
Post Ipo Equity Post Ipo Equity
Total Funding
$139.84M $119.20M
Funding Rounds
15 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Allosteric Modulators, Neurological Disorders, Pharmaceutical, Clinical-stage, Drug Development, Parkinson's Disease, Dyskinesia, Epilepsy, Addiction Treatment, Preclinical Programs, MGlu Receptors, GABAB Receptors, PTSD, Neurodegenerative Disorders, NASDAQ Biopharmaceutical, Drug Development, Clinical-stage, Central Nervous System Disorders, Anxiety Disorders, Post-traumatic Stress Disorder, Alzheimer's Disease, Cognitive Deficits, Therapeutics, Cancer Treatment, Small Molecule Development, Vascular Disruption Agents, Commercial Partnerships, Genomic Diagnostics, Neuropsychiatry
Website
addextherapeutics.com bionomics.com.au
Addex Therapeutics logo

About Addex Therapeutics

Addex Therapeutics is a Swiss-based biotechnology company founded in 2002 and listed on the SIX Swiss Exchange and NASDAQ Capital Market under the ticker symbol "ADXN." The company focuses on the development and commercialization of allosteric modulators, a novel class of orally available small mole...

Bionomics Ltd logo

About Bionomics Ltd

Bionomics Ltd Bionomics Ltd, a clinical-stage biopharmaceutical company, traded on Nasdaq as BNOX and ASX as BNO, focuses on developing novel drug candidates targeting patients with anxiety and stressor-related CNS disorders. The company's lead product candidate, BNC210, an oral, proprietary, select...

We will tell you when either one moves

BounceWatch watches Addex Therapeutics and Bionomics Ltd for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Addex Therapeutics and Bionomics Ltd — by email.

Frequently Asked Questions

Addex Therapeutics — Allosteric modulators for Human Health . Bionomics Ltd — Developing novel drug candidates to transform the lives of patients with anxiety and stressor-related CNS disorders. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Addex Therapeutics has raised $139.84M while Bionomics Ltd has raised $119.20M.
Addex Therapeutics and Bionomics Ltd operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Addex Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Addex Therapeutics on 11 Sep 2024, and Bionomics Ltd on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy